# A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)

> **NCT04718961** · PHASE2 · TERMINATED · sponsor: **Mirum Pharmaceuticals, Inc.** · enrollment: 4 (actual)

## Conditions studied

- Intrahepatic Cholestasis of Pregnancy

## Interventions

- **DRUG:** Volixibat
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04718961
- **Lead sponsor:** Mirum Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-04
- **Primary completion:** 2022-12-07
- **Final completion:** 2022-12-07
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Due to company's assessment of enrollment feasibility.
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04718961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04718961, "A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04718961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*